Diagnostic Radiology and Nuclear Medicine
Radiation Oncology, Medicine
Division Head, Nuclear Medicine
Education and Training
Vasken Dilsizian, MD, has been a professor of radiology and medicine at the University of Maryland School of Medicine since 2001, and chief of the division of nuclear medicine at the University of Maryland Medical Center in Baltimore since 2007.
He graduated from Tufts University School of Medicine in 1982. This was followed by Internal Medicine residency at Georgetown University School of Medicine in 1985, Fellowship in Cardiology at Boston University Medical Center and Massachusetts General Hospitals in 1988, and Nuclear Medicine residency at the National Institutes of Health in 1992. He holds a master's (Tau Beta Pi) and bachelor's (Magna Cum Laude) degree in chemical engineering, both from Tufts University. He is a Diplomate of the American Board of Internal Medicine, Cardiovascular Diseases, and Nuclear Medicine.
Dilsizian has been involved in many councils, committees, and task forces of the American College of Cardiology, American Heart Association, American Society of Nuclear Cardiology (ASNC) and the Society of Nuclear Medicine and Molecular Imaging (SNMMI). He was elected as the President of the SNMMI (2019-2020) and currently serving on the Board of Directors as the immediate past president (2020-2021). He served as the President of the Cardiovascular Council of the SNMMI (2013-2014) and was awarded the 2014 Hermann Blumgart Award for his innumerable contributions to the science of nuclear cardiology. He was the SNMMI Henry N. Wagner, Jr. Cardiovascular Nuclear and Molecular Imaging Lecturer in 2014 and 2015. He is on the Board of Directors of ASNC, and was the Program Chair of the ASNC 2014 Scientific Sessions. In 2016, he was bestowed as “Master” of American Society of Nuclear Cardiology (MASNC) for his contribution to the field of nuclear cardiology and for holding senior leadership positions within the Society. He serves as the Chair of the ACC Task Force on clinical competence and training in nuclear cardiology (COCATS 4 – TF6), Board of Scientific Counselors of the National Institutes of Health, Clinical Center (2018-2022), and the Vice Chairman of the Nuclear Regulatory Commission (NRC) Advisory Committee on the Medical Uses of Isotopes (ACMUI; 2021-2022).
He spent 13 years at the National Institutes of Health, where he served as the Director of Nuclear Cardiology from 1992 to 2001. His research efforts over the past 35 years have culminated into over 260 original, peer-reviewed manuscripts and invited editorials/articles, 10 books, and 50 book chapters. He has served as a Guest Editor on 5 periodicals and excerpts. He serves as the Deputy Editor of the Journal of American College of Cardiology - Cardiovascular Imaging, Section Editor of the Journal of the American College of Cardiology, and Section Editor of Current Cardiology Reports. He is a co-editor of the “Atlas of Nuclear Cardiology” (now in its 5th edition), “Cardiac CT, PET and MR” (now in its 3rd edition), and the “Atlas of Cardiac Innervation”. He is also a co-author of the “Nuclear Cardiology” chapter in Braunwald’s Heart Disease: A Textbook of Cardiovascular Medicine (2005-2018).
Clinical Specialty: Internal Medicine, Cardiovascular Diseases, Nuclear Medicine
Dilsizian V, Rocco TP, Freedman NM, Leon MB, Bonow RO. Enhanced detection of ischemic but viable myocardium by the reinjection of thallium after stress-redistribution imaging. N Engl J Med 1990; 323:141-146.
Dilsizian V, Bonow RO, Epstein SE, Fananapazir L. Myocardial ischemia detected by thallium scintigraphy is frequently related to cardiac arrest and syncope in young patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 1993; 22:796-804.
Dilsizian V, Bateman TM, Bergmann SR, Des Prez R, Magram M, Goodbody AE, Babich JW, Udelson JE. Metabolic imaging with β-methyl-β²-[123I]-iodophenyl-pentadecanoic acid (BMIPP) identifies ischemic memory following demand ischemia. Circulation 2005;112(14):2169--2174.
Dilsizian V, Eckelman WC, Loredo ML, Jagoda EM, Shirani J. Evidence for tissue angiotensin-converting-enzyme in explanted hearts of ischemic cardiomyopathy using targeted radiotracer technique. J Nucl Med 2007;48:182-187.
Dilsizian V, Zynda TK, Petrov A, Ohshima S, Tahara N, Haider N, Donohue A, Aras O, Fernia F, Hillier S, Joyal J, Wong ND, Coleman T, Babich J, Narula J. Molecular Imaging of Human ACE-1 Expression in Transgenic Rats. J Am Coll Cardiol Img 2012; 5:409-18.
Dilsizian V, Arrighi JA, Cohen RS, Miller TD, Solomon AJ, Udelson JE. COCATS 4 Task Force 6: Training in Nuclear Cardiology. J Am Coll Cardiol 2015; 65(17):1800-1809.
Dilsizian V, Bacharach SL, Beanlands SR, Bergmann SR, Delbeke D, Dorbala S, Gropler RJ, Knuuti J, Schelbert H, Travin M. ASNC Imaging Guidelines/SNMMI Procedure Standard for Positron Emission Tomography (PET) Nuclear Cardiology Procedures. J Nucl Cardiol 2016 Oct;23(5):1187-226.
Gewirtz H, Dilsizian V. Integration of Quantitative PET Absolute Myocardial Blood Flow in the Clinical Management of Coronary Artery Disease. Circulation 2016; 133:2180-96.
Gewirtz H, Dilsizian V. Myocardial Viability: Survival Mechanisms and Molecular Imaging Targets in Acute and Chronic Ischemia. Circulation Research 2017; 120:1197-1212.
Kim J, Feller ED, Chen W, Liang Y, Dilsizian V. FDG PET/CT for Early Detection and Localization of Left Ventricular Assist Device Infection: Impact on Patient Management and Outcome. J Am Coll Cardiol Img 2019; 12:722-9.
Schindler TH, Dilsizian V. Coronary Microvascular Dysfunction: Clinical Considerations and Noninvasive Diagnosis. J Am Coll Cardiol Img 2020; 13:140-155.
Chen W, Dilsizian V. Molecular Imaging of Cardiovascular Device Infection: Targeting the Bacteria or the Host-Pathogen Immune Response? J Nucl Med 2020; 61:319-26.
Chen W, Dilsizian V. Molecular Imaging of Amyloid Deposits for Early Diagnosis of Cardiac Amyloidosis and Monitoring Treatment Response. J Am Coll Cardiol Img 2020; 13:1348-52.
Dilsizian V, Gewirtz H, Marwick TH, Kwong RY, Raggi P, Al-Mallah M, Herzog C. Cardiac Imaging of Coronary Heart Disease Risk Stratification in Chronic Kidney Disease. J Am Coll Cardiol Img 2021; 14:669-82.
Awards and Honors
Magna Cum Laude, Tufts University - 1977
Tau Beta Pi, National Engineering Honor Society - 1978
Full scholarship with stipend, Tufts University Graduate School
Fellow, American College of Cardiology - 1989
Fellow, American Heart Association - 2003
The 16th Dr. Thomas E. O’Brien Memorial Lecture Award for Excellence in Medicine - 2004
Outstanding Service as an Educator, American College of Cardiology - 2005
Scientific Advisor, RSNA Research Resident Award - 2006
Scientific Advisor, RSNA Research Resident Award - 2008
The Bruce Roberts Line Award for Outstanding Research - 2009
Scientific Advisor, Nuclear Cardiology Foundation Pilot and Feasibility Award - 2009
Outstanding Teaching Achievement, Department of Radiology - 2010
The 9th Annual Mario Verani Memorial Lectureship - 2010
Scientific Advisor, RSNA Research Resident Award - 2012
Charles M. Nice, Jr., MD, PhD, Visiting Professor, Tulane University - 2014
SNMMI Hermann Blumgart Pioneer Award for Contributions to Nuclear Cardiology - 2014
SNMMI 60th Anniversary Henry N. Wagner, Jr. Cardiovascular Highlights Lecture - 2014
SNMMI Henry N. Wagner, Jr. Cardiovascular Nuclear and Molecular Imaging Lecture - 2015
Scientific Mentor, NIH K08 Grant Award 2016-2021
“Master” of the American Society of Nuclear Cardiology (MASNC) - 2016
Lifetime Achievement Award, World Federation of Cardiac Imaging and Clinical Cardiology - 2019
Fellow, Society of Nuclear Medicine and Molecular Imaging - 2020